International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines
Highlights • Global collaboration is feasible and enables comparison of vaccine formulations. • Exposure to pandemic H1N1 vaccines was associated with a slight increased risk of GBS. • Adjuvanted vaccines were not associated with higher GBS risk as compared to non-adjuvanted vaccines. • Results from...
Gespeichert in:
Veröffentlicht in: | VACCINE 2013-09, Vol.31 (40), p.4448-4458 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Global collaboration is feasible and enables comparison of vaccine formulations. • Exposure to pandemic H1N1 vaccines was associated with a slight increased risk of GBS. • Adjuvanted vaccines were not associated with higher GBS risk as compared to non-adjuvanted vaccines. • Results from pooled (mega-analytic) and meta-analytic approaches were consistent. • Low relative incidence of GBS supports recommendations for use of influenza vaccines. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2013.06.032 |